Risk of travel-associated tuberculosis

Clinical Infectious Diseases

Volumn 33, Issue 8, 2001, Pages 1393-1396

  Rieder, H L ^a  

^a Intl Union Against Tuberculosis   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL EXPOSURE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TRAVEL; TUBERCULOSIS;

HUMANS; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TRAVEL; TUBERCULOSIS, PULMONARY;

EID: 0035887967     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323127     Document Type: Review

References (30)

1. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic
2. Tuberculosis and race/ethnicity in the United States: Impact of socioeconomic status
3. Airborne infection: Theoretical limits of protection achievable by building ventilation
4. BCG-vaccine studies. 4. Further observations on the effect of light on BCG vaccine
5. Association of prevalence of tuberculin reactions with closeness of contact among household contacts of new smear-positive pulmonary tuberculosis patients
6. The Byrd study: In-depth analysis of a micro-outbreak of tuberculosis in a closed environment
7. The epidemiology of tuberculosis infection in a closed environment
8. A train passenger with pulmonary tuberculosis: Evidence of limited transmission during travel
9. Transmission of Mycobacterium tuberculosis among employees in a US Government office, Gabarone, Botswana
10. Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings
11. Transmission and dynamics of tuberculosis on generalized households
12. Tuberculosis and air travel: Guidelines for prevention and control
13. Transmission of Mycobacterium tuberculosis associated with air travel
14. Low infectivity of tuberculosis
15. Tuberculosis risk after exposure on airplanes
16. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity
17. Annual risk of infection
18. Controlled chemoprophylaxis trials in tuberculosis: A general review
19. BCG vaccination
20. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life: Final report to the Medical Research Council
21. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys
22. Mycobacterium tuberculosis infection in travellers: Tuberculosis comes home
23. Interpretation of repeated tuberculin tests: Boosting, conversion, and reversion
24. Persistence and boosting of Bacille Calmette-Guérin-induced delayed-type hypersensitivity
25. Targeted tuberculin testing and treatment of latent tuberculosis infection
26. A method for estimating the prevalence of tuberculous infection
27. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial
28. Life time risks, incubation period, and serial interval of tuberculosis
29. Public health aspects of tuberculosis: Supervision of therapy
30. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic